Literature DB >> 10480592

Bupropion hydrochloride induced serum sickness-like reaction.

A Tripathi1, P A Greenberger.   

Abstract

BACKGROUND: Bupropion hydrochloride is used frequently in the treatment of depression and in smoking cessation therapy.
METHODS: We report a case of bupropion hydrochloride induced serum sickness-like reaction.
RESULTS: There was complete resolution of symptoms on discontinuing bupropion and instituting therapy with prednisone and antihistamines.
CONCLUSION: This case is seemingly the first report of a serum sickness-like reaction to bupropion hydrochloride.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480592     DOI: 10.1016/S1081-1206(10)62630-0

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  5 in total

1.  Bupropion-Induced Delayed-Onset Anaphylaxis.

Authors:  Cameron J Risma; Matthew J Pazderka; Yon J Chong; Ashish Sharma
Journal:  Prim Care Companion CNS Disord       Date:  2015-06-25

Review 2.  Bupropion: a review of its use in the management of smoking cessation.

Authors:  K J Holm; C M Spencer
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 3.  Tolerability and safety of sustained-release bupropion in the management of smoking cessation.

Authors:  Henri-Jean Aubin
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004.

Authors:  Marie-Nöelle Beyens; Claire Guy; Genevieve Mounier; Sylvie Laporte; Michel Ollagnier
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  Delayed onset urticaria in depressive patients with bupropion prescription: a nationwide population-based study.

Authors:  Li-Yu Hu; Chia-Jen Liu; Ti Lu; Tsung-Ming Hu; Chia-Fen Tsai; Yu-Wen Hu; Cheng-Che Shen; Yu-Sheng Chang; Mu-Hong Chen; Chung-Jen Teng; Huey-Ling Chiang; Chiu-Mei Yeh; Vincent Yi-Fong Su; Wei-Shu Wang; Pan-Ming Chen; Tzeng-Ji Chen; Tung-Ping Su
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.